• Sign up
  • Login

Scheme Profile

UTI-Healthcare Fund (G)

Get detailed information of scheme on investment, NAV, Performance.
AUM ( Cr. )
1,444
Inception Date
28-06-1999
Category
Equity - Sectoral

Key Parameters

  • Type
  • OPEN ENDED
  • Minimum Investment ()
  • 5000
  • 52 Week High / Low ()
  • 344.5735 (31-Aug-2026) / 268.5857 (23-Mar-2026)
  • Incremental Investment ()
  • 1000
  • NAV ()
  • 342.84 ( -1.33) ( -0.39 %)
  • Benchmark
  • BSE Healthcare TRI
  • Fund Manager
  • Kamal Gada
  • Value of () 1,00,000 since inception
  • 34,28,406
  • Entry Load
  • Nil
  • Exit Load
  • 1.00% - If redeemed / switched out less than one year from the date of allotment. Nil - If redeemed / switched out greater than or equal to one year from the date of allotment.
  • Expense Ratio (%)
  • 2.20
  • Maturity Date
  • NA

Portfolio Indicators

  • Portfolio P/E
  • 51.70 times
  • Portfolio P/B
  • 7.59 times
  • Average Maturity
  • 0.0082 years
  • Yield To Maturity
  • 0 %
  • Modified Duration
  • 0
  • Turnover Ratio (%)
  • 28.16

Risk Factors

  • Jenson's Alpha
  • 16.68
  • Standard Deviation
  • 4.60
  • Beta
  • 0.74
  • Sharpe
  • 1.11
  • R-Squared
  • 1.00
  • Treynor Factor
  • 0.10

NAV Movement

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

AUM Growth ( Cr.)

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

Performance

  • Scheme Name
  • YTD (%)
  • 3 Months (%)
  • 6 Months (%)
  • 1 Year (%)
  • 3 Years (%)
  • 5 Years (%)
  • 10 Years (%)
  • Since Inception
  • BSE Healthcare TRI
  • 10.35
  • -0.51
  • 15.09
  • 48.32
  • 13.19
  • 22.14
  • 13.77
  • -

Company Top 5 Holdings

  [ As on 31 Aug 2026 ] More
  • Company
  • Asset
  • Value( in Cr.)
  • Holdings (%)
  • Sun Pharmaceutical Industries Ltd
  • Equity
  • 6,00,000
  • 8.25
  • Divis Laboratories Ltd
  • Equity
  • 94,707
  • 6.21
  • Net CA & Others
  • Net CA & Others
  • 0
  • 5.71
  • Ajanta Pharma Ltd
  • Equity
  • 1,90,000
  • 4.74
  • Gland Pharma Ltd
  • Equity
  • 1,85,000
  • 3.70

Sector Top 5 Holdings

  [ As on 31 Aug 2026 ] More
  • Sector
  • Value( in Cr.)
  • Holdings (%)
  • Pharmaceuticals
  • 75,84,724
  • 72.00
  • Healthcare
  • 45,24,603
  • 26.49
  • Chemicals
  • 1,70,000
  • 1.51

Annual Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
YTD 20.43 1.86 - -10.18 1,443.57
2025 -3.35 6.46 - 8.55 1,101.63
2024 41.90 18.51 10.35 8.12 1,235.91
2023 38.52 25.15 38.35 18.10 870.48
2022 -12.37 1.23 -11.31 2.80 691.46
2021 18.21 23.27 20.57 21.69 845.91
2020 66.49 27.28 62.19 15.60 649.26
2019 0.99 7.39 -3.06 13.79 394.61
2018 -7.31 2.53 -5.45 6.67 433.40
2017 5.78 29.63 0.53 28.06 385.48

Quarterly Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
Jun-2026 19.88 10.73 - 0 1,307.98
Mar-2026 -4.73 -14.34 - 0 1,055.53
Dec-2025 -1.16 5.97 - 0 1,101.63
Sep-2025 -0.22 -4.00 - 0 1,096.95

Peer Comparison

<< < 12345> >> 

Asset Allocation

Sector Allocation

Quick links

Close